# Quoin Pharmaceuticals Ltd.: Form 8-K, filed Nov 12, 2025

- Company: [Quoin Pharmaceuticals Ltd.](/companies/qnrx.md) (CIK 1671502)
- Form: 8-K
- Filed: 2025-11-12
- Accepted by EDGAR: Nov 12, 2025, 08:00 ET
- Period: 2025-11-11
- Accession: 0001104659-25-109802
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925109802/tm2530990d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671502/000110465925109802/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671502/000110465925109802/tm2530990d1_8k.htm

Filed Nov 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-109802. Last ingested by Listed: Nov 6, 2026, 18:24 ET. No prices; not investment advice.